Lung: Translocations in Squamous Cell Carcinoma by Huret, Jean-Loup
Solid Tumour Section 
Review 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(8) 545 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
Lung: Translocations in Squamous Cell 
Carcinoma 
Jean-Loup Huret 
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France 
Published in Atlas Database: October 2014 
Online updated version : http://AtlasGeneticsOncology.org/Tumors/TranslocLungSquamCellCarcID6819.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/62264/10-2014-TranslocLungSquamCellCarcID6819.pdf  
DOI: 10.4267/2042/62264
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Review on translocations in lung squamous cell 
carcinoma, with data on clinics, genetics and 
cytogenetics. 
Classification 
In the group of malignant epithelial tumours of the 
lungs, squamous cell carcinomas belong to the non-
small cell carcinomas (non-small cell lung cancer 
(NSCLC)), as opposed to small cell carcinomas 
(SCLC). Other NSCLCs are: adenocarcinomas, 
adenosquamous carcinomas, large cell carcinomas, 
sarcomatoid carcinomas, carcinoid tumours, salivary 
gland tumours. 
Clinics and pathology 
Epidemiology 
Squamous cell carcinoma is the most frequent lung 
cancer in male patients, representing about 40% of 
the cases, and only 25% in women (much less 
frequent in female patients than adenocarcinoma). 
Squamous cell carcinoma is the lung cancer the most 
often associated with tobacco smoking. Location of 
the tumour is usually central, present as a perihilar 
mass, with or without lobar collapse and obstructive 
pneumonitis, but it can also be peripheral at times. 
Pathology 
There are small cell variants (differential diagnosis: 
SCLC), clear cell variants, well-differentiated 
papillary variants, basaloid variants with a very 
aggressive clinical course, and spindle cell 
(sarcomatoid) carcinosarcoma variants of the typical 
squamous cell carcinoma.  
The expression of cytokeratins (CK) CK5/6, 
CK34BE12 and TP63 (3q28, also called P63) are 
strong in squamous cell carcinoma, whereas the 
expression of CK7 and NKX2-1 (14q13, also called 
TTF-1) are strong in adenocarcinoma (Xu et al., 
2014). 
Evolution 
Staging is performed according to the TNM system. 
Genetics 
Note 
TP53 (17p13) mutations are detected in most cases. 
In a large recent study, altered pathways included 
NFE2L2/KEAP1 in 34%, squamous differentiation 
genes in 44%, PI3K/AKT in 47%, and 
CDKN2A/RB1 in 72% of tumors. In contrast to what 
is found in adenocarcinoma, mutations in EGFR 
(7p11) or in KRAS (12p12) are extremely rare in 
squamous cell carcinoma of the lungs (Cancer 
Genome Atlas Research Network, 2012). DDR2 
(1q23) is inactivated in about 4% of cases; FGFR1 
(8p11) and FGFR3 (4p16) are amplified in 5 to 10% 
of cases (Majewski et al., 2013; Seo et al., 2014). 
Cytogenetics 
Note 
Of 157 translocations so far reported in squamous 
cell carcinoma of the lungs, 1 gene was found five 
times implicated: ATP11B (3q26, which catalyzes 
the hydrolysis of ATP); 1 gene was implicated in 
three different translocations: MCF2L2 (3q27, a 






Atlas Genet Cytogenet Oncol Haematol. 2015; 19(8) 546 
 
guanine nucleotide exchange factor); and 13 genes 
were found twice: ANGPT1 (8q23), EIF4EBP1 
(8p11), EML4 (2p21), IGF2 (11p15), ITSN1 
(21q22), KLHL29 (2p24), MAN1A2 (1p13), 
MGAT5 (2q21), NPAS3 (14q13), PPP6R3 (14q13), 
ROS1 (6q22), TMCC1 ( 3q22), and TTC28 (22q12). 
Finally, 280 genes were found implicated in one 
translocation. 
Cytogenetics Morphological 
The translocations are the following: 
t(1;1)(p36;p36) PRKCZ/SKI (Majewski et al., 2013) 
t(1;1)(p34;q44) SMYD3/ELOVL1 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;1)(q21;q21) GATAD2B/PRKAB2 (Cancer 
Genome Atlas Research Network, 2012)  
t(1;2)(p35;q37) ZBTB8B/TRAF3IP1 (Cancer 
Genome Atlas Research Network, 2012)  
t(1;2)(p12;p16) REL/MAN1A2 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;2)(p12;p15) PHGDH/WDPCP (Cancer Genome 
Atlas Research Network, 2012)  
t(1;3)(p34;q26) ATP11B/POU3F1 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;3)(p34;q26) OSCP1/SOX2-OT (Cancer Genome 
Atlas Research Network, 2012)  
t(1;3)(p33;q29) TFRC/NSUN4 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;4)(p31;q22) BMPR1B/ALG6 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;5)(p34;q31) CTNNA1/HEYL (Cancer Genome 
Atlas Research Network, 2012)  
t(1;5)(q25;p13) DARS2/ZFR (Cancer Genome Atlas 
Research Network, 2012)  
t(1;8)(p36;q21) SLC7A13/WDTC1 (Cancer 
Genome Atlas Research Network, 2012)  
t(1;8)(p32;q24) NRD1/KCNK9 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;9)(p33;p13) KIF24/FAAH (Cancer Genome 
Atlas Research Network, 2012)  
t(1;10)(p32;q21) CDK1/USP24 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;10)(p31;p14) SFMBT2/PRKACB (Cancer 
Genome Atlas Research Network, 2012)  
t(1;10)(q32;q22) TMEM206/PSAP (Cancer 
Genome Atlas Research Network, 2012)  
t(1;11)(p31;q24) ETS1/NEGR1 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;12)(q25;p12) HMCN1/ETNK1 (Cancer Genome 
Atlas Research Network, 2012)  
t(1;16)(q21;p12) CCP110/GOLPH3L (Cancer 
Genome Atlas Research Network, 2012)  
t(1;17)(p21;q25) UNK/DPYD (Cancer Genome 
Atlas Research Network, 2012)  
t(1;17)(p12;q11) ALDOC/MAN1A2 (Cancer 
Genome Atlas Research Network, 2012)  
t(1;21)(p35;q22) ITSN1/MATN1 (Cancer Genome 
Atlas Research Network, 2012)  
t(2;2)(p25;p25) ROCK2/SH3YL1 (Cancer Genome 
Atlas Research Network, 2012)  
t(2;2)(p24;p23) GPN1/KLHL29 (Cancer Genome 
Atlas Research Network, 2012)  
inv(2)(p21p23) or del(2)(p21p23) EML4/ALK 
(Rikova et al., 2007; Soda et al., 2007; Martelli et al., 
2009) 
t(2;2)(p21;p21) THADA/EML4 (Cancer Genome 
Atlas Research Network, 2012)  
t(2;2)(p16;p23) PSME4/PPP1CB (Cancer Genome 
Atlas Research Network, 2012)  
t(2;2)(p15;p15) EHBP1/FAM161A (Cancer 
Genome Atlas Research Network, 2012)  
t(2;2)(q21;q21) GPR39/MGAT5 (Cancer Genome 
Atlas Research Network, 2012)  
t(2;2)(q21;q24) ACVR1C/MGAT5 (Cancer 
Genome Atlas Research Network, 2012)  
t(2;2)(q23;q35) TNS1/RPRM (Cancer Genome 
Atlas Research Network, 2012)  
t(2;3)(p16;q26) KCNMB2/NRXN1 (Cancer 
Genome Atlas Research Network, 2012)  
t(2;4)(p16;q13) BCL11A/EPHA5 (Cancer Genome 
Atlas Research Network, 2012)  
t(2;5)(p16;p15) NRXN1/PLEKHG4B (Cancer 
Genome Atlas Research Network, 2012)  
t(2;5)(p11;p12) HCN1/FUNDC2P2 (Cancer 
Genome Atlas Research Network, 2012)  
t(2;5)(q35;p13) USP37/OSMR (Cancer Genome 
Atlas Research Network, 2012)  
t(2;6)(p24;p22) ID4/FAM84A (Cancer Genome 
Atlas Research Network, 2012)  
t(2;16)(q24;q11) ANKRD26P1/SLC4A10 (Cancer 
Genome Atlas Research Network, 2012)  
t(2;17)(p25;q21) CRHR1-IT1/ALLC (Cancer 
Genome Atlas Research Network, 2012)  
t(2;18)(p24;q11) KLHL29/PSMA8 (Cancer 
Genome Atlas Research Network, 2012)  
t(2;22)(p12;q12) EVA1A/TTC28 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(p12;q29) PAK2/VGLL3 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q11;q13) ALCAM/EPHA6 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q12;q13) GSK3B/IMPG2 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q13;q22) SLCO2A1/GUCA1C (Cancer 
Genome Atlas Research Network, 2012)  
t(3;3)(q21;q22) RUVBL1/TMCC1 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q22;q22) PIK3CB/BFSP2 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q22;q22) TMCC1/C3orf36 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q24;q26) HLTF/OTOL1 (Cancer Genome  
 
Atlas Research Network, 2012)  
t(3;3)(q25;q25) GMPS/C3orf55 (Cancer Genome 
Atlas Research Network, 2012)  
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t(3;3)(q25;q26) IQCJ/BCHE (Cancer Genome Atlas 
Research Network, 2012)  
t(3;3)(q25;q27) PPM1L/MCF2L2 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q25;q28) PYDC2/C3orf79 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q26;q26) ATP11B/SI (Cancer Genome Atlas 
Research Network, 2012)  
t(3;3)(q26;q26) PHC3/FNDC3B (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q26;q27) CCDC39/MCF2L2 (Cancer 
Genome Atlas Research Network, 2012)  
t(3;3)(q26;q28) SOX2/TPRG1 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q27;q28) LPP/ST6GAL1 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q27;q29) EHHADH/SENP5 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;3)(q29;q29) LRCH3/MIR570 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;4)(q26;p16) ATP11B/ZNF595 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;8)(q27;q22) MCF2L2/MIR548A3 (Cancer 
Genome Atlas Research Network, 2012)  
t(3;8)(q29;p12) FYTTD1/WRN (Cancer Genome 
Atlas Research Network, 2012)  
t(3;11)(q26;p15) PDE3B/ATP11B (Cancer Genome 
Atlas Research Network, 2012)  
t(3;13)(q21;q33) TNFSF13B/MYLK (Cancer 
Genome Atlas Research Network, 2012)  
t(3;17)(q25;p11) MAP2K3/SSR3 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;17)(q29;q23) MIR21/WDR53 (Cancer Genome 
Atlas Research Network, 2012)  
t(3;19)(q27;q13) ACTN4/IGF2BP2 (Cancer 
Genome Atlas Research Network, 2012)  
t(3;20)(q21;q13) SLC12A8/BCAS1 (Cancer 
Genome Atlas Research Network, 2012)  
t(3;21)(p11;q21) POU1F1/TMPRSS15 (Cancer 
Genome Atlas Research Network, 2012)  
t(3;22)(q26;q11) ATP11B/TPTEP1 (Cancer 
Genome Atlas Research Network, 2012)  
del(4)(p16p16) FGFR3/TACC3 (Majewski et al., 
2013; Wu et al. 2013)  
t(4;4)(q13;q22) CCSER1/UGT2A1 (Cancer 
Genome Atlas Research Network, 2012)  
t(4;6)(p15;q22) SLC34A2/ROS1 (Davies et al., 
2012)  
t(4;8)(q13;q24) COX18/ZFAT (Cancer Genome 
Atlas Research Network, 2012)  
t(4;9)(q13;q32) ADAMTS3/SNX30 (Cancer 
Genome Atlas Research Network, 2012)  
t(4;10)(p13;q11) SGMS1/KCTD8 (Cancer Genome 
Atlas Research Network, 2012)  
t(5;5)(p15;p15) MARCH6/IRX4 (Cancer Genome  
 
Atlas Research Network, 2012)  
t(5;5)(p15;p15) ROPN1L/SEMA5A (Cancer 
Genome Atlas Research Network, 2012)  
t(5;5)(p12;p13) RICTOR/FGF10 (Cancer Genome 
Atlas Research Network, 2012)  
t(5;6)(q33;q22) CD74/ROS1 (Davies et al., 2012)  
t(5;8)(p15;q21) MRPS28/ADAMTS16 (Cancer 
Genome Atlas Research Network, 2012)  
t(5;8)(p13;p11) EIF4EBP1/PRKAA1 (Cancer 
Genome Atlas Research Network, 2012)  
t(5;11)(q14;q22) FAM151B/CASP12 (Cancer 
Genome Atlas Research Network, 2012)  
t(5;11)(q35;q14) KCNIP1/KCTD14 (Cancer 
Genome Atlas Research Network, 2012)  
t(5;12)(p12;q13) NNT/AMIGO2 (Cancer Genome 
Atlas Research Network, 2012)  
t(6;6)(p25;p25) FAM50B/PPP1R3G (Cancer 
Genome Atlas Research Network, 2012)  
t(6;6)(p22;q12) EYS/DEK (Cancer Genome Atlas 
Research Network, 2012)  
t(6;6)(p21;p21) HLA-DOA/MUC21 (Cancer 
Genome Atlas Research Network, 2012)  
t(6;6)(p12;p22) BEND6/TRIM38 (Cancer Genome 
Atlas Research Network, 2012)  
t(6;6)(p12;q14) FAM83B/HTR1E (Cancer Genome 
Atlas Research Network, 2012)  
t(6;6)(q14;q15) GABRR2/ME1 (Cancer Genome 
Atlas Research Network, 2012)  
t(6;13)(p21;q12) RPL7L1/CDK8 (Cancer Genome 
Atlas Research Network, 2012)  
t(6;14)(q24;q24) SASH1/DPF3 (Cancer Genome 
Atlas Research Network, 2012)  
t(6;16)(q13;p13) NTAN1/SLC17A5 (Cancer 
Genome Atlas Research Network, 2012)  
t(7;7)(p11;p12) VOPP1/GRB10 (Cancer Genome 
Atlas Research Network, 2012)  
t(7;7)(q22;q31) ANKRD7/DUS4L (Cancer Genome 
Atlas Research Network, 2012)  
t(7;7)(q31;q33) CHCHD3/MET (Cancer Genome 
Atlas Research Network, 2012)  
t(7;8)(p14;p23) AMPH/FDFT1 (Majewski et al., 
2013)  
t(7;10)(q36;q25) ACTR3C/SORCS1 (Cancer 
Genome Atlas Research Network, 2012)  
t(8;8)(p11;p11) ADAM9/RNF170 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;8)(p11;p11) BAG4/FGFR1 (Wu et al., 2013)  
t(8;8)(p11;p11) LETM2/KCNU1 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;8)(q11;q11) PRKDC/C8orf22 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;8)(q23;q23) CSMD3/ANGPT1 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;8)(q23;q23) OXR1/RSPO2 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;9)(p12;p13) PURG/UBAP1 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;9)(p11;p21) EIF4EBP1/C9orf53 (Cancer  
 
Genome Atlas Research Network, 2012)  
t(8;10)(p21;q26) FGFR2/KIAA1967 (Wu et al., 
2013)  
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t(8;10)(q23;q11) ANGPT1/CXCL12 (Cancer 
Genome Atlas Research Network, 2012)  
t(8;11)(q21;p15) HTATIP2/CA1 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;15)(q21;q21) NEDD4/RDH10 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;16)(p11;p12) KIAA0556/LSM1 (Cancer 
Genome Atlas Research Network, 2012)  
t(8;16)(q22;q24) GSE1/NACAP1 (Cancer Genome 
Atlas Research Network, 2012)  
t(8;21)(q11;q21) UBE2V2/NRIP1 (Cancer Genome 
Atlas Research Network, 2012)  
t(9;9)(p21;p21) CDKN2A/FOCAD (Cancer 
Genome Atlas Research Network, 2012)  
t(9;9)(p21;p13) PLAA/RUSC2 (Cancer Genome 
Atlas Research Network, 2012)  
t(9;19)(p13;p13) FAM219A/S1PR5 (Cancer 
Genome Atlas Research Network, 2012)  
inv(10)(p11q11) KIF5B/RET (Cai et al., 2013)  
t(10;11)(q21;p15) CTNNA3/IGF2 (Cancer Genome 
Atlas Research Network, 2012)  
t(10;11)(q22;q14) P4HA1/TRIM77P (Cancer 
Genome Atlas Research Network, 2012)  
t(10;17)(q22;q12) SAMD8/LHX1 (Cancer Genome 
Atlas Research Network, 2012)  
t(10;20)(q23;q13) WAPAL/PTPRT (Cancer 
Genome Atlas Research Network, 2012)  
t(11;11)(p14;p13) EIF3M/MPPED2 (Cancer 
Genome Atlas Research Network, 2012)  
t(11;11)(p11;q12) OR9Q1/OR4C46 (Cancer 
Genome Atlas Research Network, 2012)  
t(11;11)(q12;q12) P2RX3/RTN4RL2 (Majewski et 
al., 2013)  
t(11;11)(q12;q13) EEF1G/PPP6R3 (Cancer Genome 
Atlas Research Network, 2012)  
t(11;11)(q12;q13) SHANK2/MS4A8B (Cancer 
Genome Atlas Research Network, 2012)  
t(11;11)(q13;q22) PPP6R3/CNTN5 (Cancer 
Genome Atlas Research Network, 2012)  
t(11;12)(p11;p13) ERC1/SPI1 (Cancer Genome 
Atlas Research Network, 2012)  
t(12;20)(q12;q13) TAF4/ALG10B (Cancer Genome 
Atlas Research Network, 2012)  
t(12;22)(q14;q12) SLC16A7/TTC28 (Cancer 
Genome Atlas Research Network, 2012)  
t(13;20)(q12;p12) MACROD2/MPHOSPH8 
(Cancer Genome Atlas Research Network, 2012)  
t(14;14)(q11;q13) NPAS3/OXA1L (Cancer Genome 
Atlas Research Network, 2012)  
t(14;14)(q12;q13) FOXG1/NPAS3 (Cancer Genome 
Atlas Research Network, 2012)  
t(14;14)(q13;q21) MBIP/C14orf183 (Cancer 
Genome Atlas Research Network, 2012)  
t(14;14)(q13;q21) SEC23A/IGBP1P1 (Cancer 
Genome Atlas Research Network, 2012)  
t(16;16)(q12;q13) FTO/HERPUD1 (Majewski et al., 
2013)  
t(16;16)(q23;q24) JPH3/OSGIN1 (Cancer Genome 
Atlas Research Network, 2012)  
t(16;22)(p12;q11) POM121L4P/LCMT1 (Cancer 
Genome Atlas Research Network, 2012)  
t(17;17)(p13;p11) PIGL/RABEP1 (Cancer Genome 
Atlas Research Network, 2012)  
t(17;17)(p11;q11) AKAP10/PSMD11 (Cancer 
Genome Atlas Research Network, 2012)  
t(17;17)(p11;q11) KIAA0100/ALKBH5 (Cancer 
Genome Atlas Research Network, 2012)  
t(17;17)(q23;q23) RPS6KB1/VMP1 (Majewski et 
al., 2013)  
t(18;22)(q12;q11) CDC45/RIT2 (Cancer Genome 
Atlas Research Network, 2012)  
t(19;19)(p13;p12) UNC13A/ZNF492 (Cancer 
Genome Atlas Research Network, 2012)  
t(19;19)(q13;q13) BCL3/HIPK4 (Cancer Genome 
Atlas Research Network, 2012)  
t(19;19)(q13;q13) SIPA1L3/CD22 (Cancer Genome 
Atlas Research Network, 2012)  
t(19;21)(p13;q22) ITSN1/ZNF490 (Cancer Genome 
Atlas Research Network, 2012)  
t(19;22)(p12;q11) MMP11/ZNF714 (Cancer 
Genome Atlas Research Network, 2012)  
t(20;20)(q11;q13) ADNP/DLGAP4 (Cancer 
Genome Atlas Research Network, 2012)  
t(20;22)(q11;q12) PISD/RBL1 (Cancer Genome 
Atlas Research Network, 2012)  
t(22;22)(q11;q11) THAP7/PRODH (Cancer 
Genome Atlas Research Network, 2012)  
t(22;22)(q12;q12) APOL3/ISX (Cancer Genome 
Atlas Research Network, 2012)  
t(22;22)(q12;q12) MCM5/TOM1 (Majewski et al., 
2013) 
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